Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 1Depression 1Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 2Ketamine 2Cognitive Behavioral Therapy 2Waiting Lists 1Uncertainty 1Therapeutics 1Single Person 1Psychosocial Intervention 1Pharmacogenomic Testing 1Mindfulness-Based Stress Reduction 1Midazolam 1Interviews as Topic 1Drug Therapy 1Control Groups 1Citalopram 1Behavior Therapy 1Analgesia 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Citalopram × Lymphoid × Clear all
NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Kalaco Scientific, Inc.

Phase 2 Completed
120 enrolled
Lymphoid

Anxiety Disorders, Depression, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡